CLINICAL_TRIALS
trial_result
· 2013-05-06
Clinical Trial Update: Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone [Phase 4]
Summary
A Phase 4 trial evaluated intrathyroid injections of dexamethasone to prevent relapse in Graves' disease, and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xiao-Ming Mao | Conditions: Graves' Disease | Phase 4 | Status: COMPLETED